期刊
EUROPEAN JOURNAL OF PHARMACOLOGY
卷 741, 期 -, 页码 104-111出版社
ELSEVIER
DOI: 10.1016/j.ejphar.2014.07.036
关键词
Alzheimer's disease; BDNF; beta-amyloid; Lycopene; Anti-oxidant
资金
- Indian Council of Medical Research (ICMR), New Delhi [2007-03340]
Lycopene has attracted significant research interest due to its beneficial therapeutic effects, which include anti-oxidant, neuro-protective and anti-cancer effects, but the mechanisms of its beneficial action are not clear so far. The present study was carried out to elucidate the neuroprotective effect of lycopene against the beta-amyloid induced cognitive impairment and mitochondria oxidative damage in rats. beta-amyloid (beta-A(1-42)) was administered through intracerebroventricular (ICV) by using stereotaxic instrument in male Wistar rats. Lycopene (2.5 and 5 mg/kg) was administrated for three weeks. Behavioral performances were conducted during the study. The rats were sacrificed on the 21st day following the last behavioral test and cytoplasmic fractions of hippocampus were prepared for the quantification of acetylcholinesterase, oxidative stress parameter, mitochondrial enzymes, and inflammatory mediator like TNF-alpha, Il-6 activities, caspase-3 and BDNF. ICV beta-A(1-42) resulted in poor memory retention in Morris water maze and caused marked oxidative stress as indicated by significant increase in oxidative, mitochondria damage, TNF-alpha, IL-6 and Caspase-3 activity. We also found that beta-A(1-42) induced animal altered BDNF level than control animals. Chronic administration of lycopene resulted in an improvement in memory retention, attenuation of mitochondrial-oxidative damage, reduced neuro-inflammation and restoration of BDNF level in beta-A(1-42) treated rats. These studies indicated that lycopene helps to protect beta-A(1-42) induced cognitive dysfunction and modulates amyloidogenesis. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据